ETHYL (R)-2-((2R,3R,5R)-2-ALLYL-5-(NAPHTHALEN-2-YL)TETRAHYDROFURAN-3-YL)-2-((4-METHYLPHENYL)SULFONAMIDO)ACETATE

Catalog No. :
ACOSZD261
CAS No. :
839710-69-9
Molecular Formula :
C28H31NO5S
Molecular Weight :
493.63

IUPAC Name:ethyl (R)-2-((2R,3R,5R)-2-allyl-5-(naphthalen-2-yl)tetrahydrofuran-3-yl)-2-((4-methylphenyl)sulfonamido)acetate

ETHYL (R)-2-((2R,3R,5R)-2-ALLYL-5-(NAPHTHALEN-2-YL)TETRAHYDROFURAN-3-YL)-2-((4-METHYLPHENYL)SULFONAMIDO)ACETATE structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$211.00Login to see priceInquiryInquiry
1g95%$529.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameETHYL (R)-2-((2R,3R,5R)-2-ALLYL-5-(NAPHTHALEN-2-YL)TETRAHYDROFURAN-3-YL)-2-((4-METHYLPHENYL)SULFONAMIDO)ACETATE
IUPAC Nameethyl (R)-2-((2R,3R,5R)-2-allyl-5-(naphthalen-2-yl)tetrahydrofuran-3-yl)-2-((4-methylphenyl)sulfonamido)acetate
Molecular FormulaC28H31NO5S
Molecular Weight493.63
SMILESO=C([C@H](NS(=O)(C1=CC=C(C=C1)C)=O)[C@@H]2[C@H](O[C@H](C2)C3=CC=C4C=CC=CC4=C3)CC=C)OCC
InChI KeyJKBLWDBOKUEEQU-FICKONGGSA-N
Synonym3-Furanacetic acid, tetrahydro-α-[[(4-methylphenyl)sulfonyl]amino]-5-(2-naphthalenyl)-2-(2-propen-1-yl)-, ethyl ester, (αR,2R,3R,5R)-
CAS No.839710-69-9

Synthetic Route by SureRoute

1. ACOSZD261 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOSZD261 route product structure diagram
    ACOSZD261839710-69-9
Inquiry

2. ACOSZD261 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUEAM185 route compound structure diagram
    ACUEAM18532316-92-0 In Stock
  4. Then
  5. ACOSZD261 route product structure diagram
    ACOSZD261839710-69-9
Inquiry

Comments (0)